Coherus Oncology, Inc.CHRSNASDAQ
Loading
Pre-Tax Margin Over TimeContracting
Percentile Rank38
Studio
Year-over-Year Change

Pre-tax income as a percentage of revenue

Percentile
P38
Within normal range
vs 5Y Ago
-15.2x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM-434.23%-4166.5%
202410.68%+111.5%
2023-92.62%+33.0%
2022-138.24%-57.2%
2021-87.92%-408.3%
202028.52%+9.5%
201926.06%+100.2%
2018-13458.16%+12.1%
2017-15314.01%-22682.1%
2016-67.22%-